Abstracts - Eric Fossel

1.   Fossel ET, Solomon AK.  Communication among cellular glycolytic enzymes:  31P NMR evidence from ouabain addition to red cell membranes.  Biophys J 1977; 17:27a.

2.   Strong LH, Fossel ET, Gergely J.  19F‑NMR studies of calcium induced changes  in troponin.  Biophys J 1977; 17:118a.

3.   Koehler LS, Fossel ET, Koehler KA.  Fluorine‑19 nuclear magnetic resonance  investigation of the interaction between halothane and dipalmitoyl phosphatidylcholine multilayer vesicles.  Abstract #2297.  Fed Proc 1977; 36:708.

4.   Fossel ET.  Field dependence of 31P linewidths, T1 and NOE values in molecules of biological interest.  Abstracts of the 18th Experimental NMR Conference, Asilomar, CA, 1977:III-5.

5.   Neuringer LJ, Fossel ET.  1H and 13C NMR studies of insulin.  Abstracts of the 18th Experimental NMR Conference, Asilomar, CA, 1977:I-12.

6.   Fossel ET, Kramer MF, Taegtmeyer H, Ingwall JS.  Phosphorus‑31 nuclear magnetic resonance of perfused rat hearts -- studies during anoxia and recovery.  Abstract #880.  Circulation 1977; 56(Suppl):III-227.

7.   Fossel ET, Kramer MF, Taegtmeyer H, Ingwall JS.  31P nuclear magnetic resonance studies of high energy phosphate metabolism in perfused hearts -- anoxia and recovery.  J Cell Biol 1977; 75:329a.

8.   Fossel ET, Ingwall JS.  Protection of high-energy phosphate levels in hearts during severe hypoxia.  Biophys J 1978; 21:34a.

9.   Fossel ET, Solomon AK.  Megadalton glycolytic enzyme complex in human red cells.  Biophys J 1978; 21:81a.

10.  Fossel ET.  31P NMR observation of the steady state intermediate in myosin hydrolysis of ATP.  Biophys J 1978; 21:106a.

11.  Fossel ET, Solomon AK.  The influence of Na/K ratios on binding of G3PDH to red cell membrane vesicles.  J Cell Biol 1978; 79:235a.

12.  Fossel ET, Kramer MF, Harrison WG, Ingwall JS.  Changes in the rate of ATP formation during the cardiac cycle using inversion transfer 31P NMR.  J Cell Biol 1978; 79:328a.

13.  Fossel ET, Ingwall JS, Goldman MR, Pohost GM.  Fluoride, a new marker of myocardial injury:  A 19-F nuclear magnetic resonance study.  Abstract #7.  Circulation 1978; 58(Suppl):II-5.

14.  Fossel ET, Kramer MF, Harrison WG, Ingwall JS.  Measurement of high-energy  phosphate levels in the cardiac cycle using gated 31-P nuclear magnetic resonance.  Abstract #570.  Circulation 1978; 58(Suppl):II-146.

15.  Fossel ET, Solomon AK.  Relation between state of red cell cation pump and  glyceraldehyde 3-phosphate dehydrogenase 31P NMR resonance.  Biophys J 1979; 25:151a.

16.  Koehler LS, Jain MK, Fossel ET, Koehler KA.  Halothane effects of phospholipid bilayers.  Biophys J 1979; 25:178a.

17.  Norwood WI, Norwood CR, Ingwall JS, Fossel ET.  31P nuclear magnetic resonance (NMR) studies of ischemia in isolated perfused rat brain at 37oC and at 20oC.  Biophys J 1979; 25:275a.

18.  DeFuria R, Dygert M, Fossel ET, Ingwall JS.  Mass action ratios for  mitochondrial creatine kinase in heart:  evidence for compartmentalization.  Biophys J 1979; 25:275a.

19.  Whitfield CF, Fossel ET.  Role of free sulfhydryl groups in sugar transport  regulation.  Abstract #4756.  Fed Proc 1979; 38:1128.

20.  DeFuria R, Dygert M, Fossel ET, Ingwall JS.  An unexpected apparent equilibrium constant for the mitochondrial creatine kinase conversion:  A compartmentalization effect.  Abstract #6126.  Fed Proc 1979; 38:1388.

21.  Goldman MR, Fossel ET, Ingwall J, Pohost GM.  Feasibility of 19-F as an agent for NMR imaging of myocardial infarction: an in vitro study.  J Nuc Med 1979; 20:604.

22.  Ingwall J, Kramer M, Fossel E.  ATP synthesis following anoxic insult in isolated perfused rat hearts: capacity of the salvage pathway.  Abstract #31.  Circulation 1979; 60(Suppl):II-11.

23.  Fossel ET, Solomon AK.  Relation between red cell membrane (Na,K)-ATPase and band 3.  Abstract #578.  Fed Proc 1980; 39:807.

24.  Fossel ET, Ingwall JS.  31-P NMR of isolated perfused working hearts:  Dynamics of the heartbeat.  Abstract #2683.  Fed Proc 1980; 39:2113.

25.  Ingwall JS, Fossel ET.  Measurement of unidirectional phosphate fluxes in the creatine kinase reaction in normal and spontaneously hypertensive rat hearts using 31-P saturation transfer NMR.  Abstract #47.  Circulation 1980; 62(Suppl):III-19.

26.  Pernot A-C, Ingwall JS, Bercot M, Piwnica A, Menasche P, Fossel ET.  Evaluation of high-energy phosphate metabolism during cardioplegic circulatory arrest and reperfusion:  A P‑31 nuclear magnetic resonance study.  Presented at the Samson Thoracic Surgical Society, Boston, MA, March 1980.

27.  Fossel ET, DeLayre J, Ingwall JS.  Potential of nuclei other than protons in  NMR imaging.  Presented at the Nuclear Magnetic Resonance Imaging Symposium, Vanderbilt University School of Medicine, Nashville, TN, 1980.  J Comput Assist Tomogr 1981; 5:301‑302.

28.  Goldman MR, Fossel ET, Ingwall JS, Pohost GM.  Use of 19F NMR for evaluation of ischemic and infarcted myocardium.  Presented at the Nuclear Magnetic Resonance Imaging Symposium, Vanderbilt University School of Medicine, Nashville, TN, 1980.  J Comput Assist Tomogr 1981; 5:304.

29.  Malloy CR, Smith TW, DeLayre JL, Fossel ET.  Observation of intracellular sodium in a Langendorff perfused rat heart by Na-23 NMR.  Abstracts of the 22nd Experimental NMR Conference, Asilomar, CA, 1981:VII-3.

30.  Duval-Arnold M, Ingwall JS, Menasche P, Fossel ET.  Beneficial effects of inosine on cardiac metabolism during and after ischemic cardioplegic arrest - a P‑31 NMR study.  Abstract #555.  Circulation 1981; 64(Suppl):IV-148.

31.  Fossel ET, Post RL, O'Hara D, Smith TW.  P‑31 NMR observation of the phosphoenzyme intermediates of NaK-activated and Ca-activated ATPases.  Abstract #615.  Circulation 1981; 64(Suppl):IV-163.

32.  Goldhaber SZ, Pohost GM, Alpert NM, Newell JB, Cywinski LM, Ingwall JS, Fossel  ET.  Effects of reduced coronary flow on thallium‑201 washout.  Abstract #917.  Circulation 1981; 64(Suppl):IV-241.

33.  Kobayashi K, Fossel E, Ingwall J.  Analysis of the creatine kinase reaction in the isolated perfused rat heart using P‑31 NMR saturation transfer.  Biophys J 1982; 37:123a.

34.  Marchandise X, Graff R, Epstein F, Pike M, Brezis M, Silva P, Ingwall J, DeLayre JL, Fossel ET.  Na‑23 NMR observation of intra and extracellular sodium in the isolated perfused rat kidney.  Proceedings of the Society of Magnetic Resonance in Medicine, 1982:96-97.

35.  Pike MM, Fossel ET, Smith TW, Springer CS Jr.  High resolution 23Na NMR studies of human erythrocytes: use of aqueous shift reagents.  Proceedings of the Society of Magnetic Resonance in Medicine, 1982:123-124.

36.  Graff R, Fossel ET, Delayre JL.  Multi-nuclei surface coil at 8.2 Tesla.  Pro-ceedings of the 23rd Experimental NMR Conference, April 1982:B-16.

37.  Balschi JA, Jensen D, Pike MM, Hoefeler H, Cirillo VP, DeLayre J, Springer CS  Jr, Fossel ET.  Sodium efflux from sodium-rich yeast.  Simultaneous observation with sodium‑23 and phosphorus‑31 NMR spectroscopy in vivo.  Abstract #13.  Proceedings of the Society of Magnetic Resonance in Medicine, 1983:22.  Magn Reson Med 1984; 1:96.

38.  Fossel ET.  Observation of intracellular Ca‑43 and Mg‑25 in isolated perfused rat hearts at  8.45T.  Abstract #237.  Proceedings of the Society of Magnetic Resonance in Medicine, Works in Progress, 1983:17.  Magn Reson Med 1984; 1:291-292.

39.  DeLayre JL, Jensen D, Baldo J, Pike MM, Fossel ET.  Stereo NMR spectroscopy.  Abstract #238.  Proceedings of the Society of Magnetic Resonance in Medicine, Works in Progress, 1983:18.  Magn Reson Med 1984: 1:292.

40.  Fossel ET.  Proton NMR spectroscopy of normal and malignant tissue.  Presented at the Research and Clinical Applications of Nuclear Magnetic Resonance in Cancer, The Organ Systems Program of the National Cancer Institute, New Orleans, LA, 1984.

41.  Fossel ET, Hoefeler H.  A model of metabolic compartmentation:  immobilized  enzymes in a flowing system.  Proceedings of the Society of Magnetic Resonance in Medicine, 1984:235.

42.  Fossel ET, Hoefeler H.  Observation and quantitation of intracellular potassium and sodium in isolated perfused rat hearts by NMR.  Proceedings of the Society of Magnetic Resonance in Medicine, 1984:236.

43.  Fossel ET, Reis MA.  Proton NMR spectroscopic study of isolated skeletal muscle.  A re-investigation of non-freezable water.  Works in Progress.  Proceedings of the Society of Magnetic Resonance in Medicine, 1984.

44.  Fossel ET, Hoefeler H.  The effect of complete inhibition of creatine kinase in isolated perfused rat hearts.  Proceedings of the Society of Magnetic Resonance in Medicine, 1985:655.

45.  Fossel ET, Hoefeler H.  Myocardial intracellular potassium.  Proceedings of the Society of Magnetic Resonance in Medicine, 1986:871.

46.  Burstein D, Fossel ET.  Measurement of intracellular sodium relaxation times in a perfused frog heart.  Proceedings of the Society of Magnetic Resonance in Medicine, 1986:873.

47.  Burstein D, Fossel ET.  Measurement of intracellular sodium changes in a perfused frog heart.  Proceedings of the Society of Magnetic Resonance in Medicine, 1986:875.

48.  Reis MA, Fossel ET.  Na‑23 and K‑39 spectroscopy of excised sciatic nerve.  Proceedings of the Society of Magnetic Resonance in Medicine, 1986:1019.

49.  Fossel ET, Hoefeler H.  Complete inhibition of creatine kinase in isolated perfused rat hearts.  Abstract #1301.  Presented at the Scientific Sessions of the American Heart Association, Dallas, TX.  Circulation 1986; 74(Suppl):II-326.

50.  Fossel ET.  Water-suppressed 1H NMR spectroscopy of human tissue and body fluid.  Presented at the Santa Fe NMR Workshop, October 1986.  Santa Fe NMR Workshop Syllabus, 1986:5.

51.  Fossel ET, Carr JM, McDonagh J.  A new, highly accurate, general method for detection of malignancy.  Water-suppressed proton NMR spectroscopy of plasma.  Presented at the 28th Annual Meeting of the American Society of Hematology, San Francisco, December 1986.

52.  Fossel ET, Carr JM, McDonagh J.  Detection of malignancy in breast and lung by water-suppressed proton NMR spectroscopy of plasma.  Presented at the American Society for Clinical Investigation.  Clin Res 1987; 35:629A. 

53.  Simon M, Fossel E.  The impending demise of biopsy for lung cancer - the impact of the NMR spectroscopic blood test.  Presented at the Fleischner Society Scientific Meeting, San Francisco, CA, May 1987.

54.  Fossel ET, Carr JM, McDonagh J.  Discrimination of malignant tumors in breast and lung tissues by water-suppressed proton NMR spectroscopy of plasma.  Proceedings of the Society of Magnetic Resonance in Medicine, 1987:40.

55.  Kormos D, Modic MT, Rabinovitch AL, Alfidi RJ, Starewicz PM, Fossel ET, Smith ICP.  A PRESAT-IR-SE sequence for oncolipic spectroscopy.  Proceedings of the Society of Magnetic Resonance in Medicine, 1987:492.

56.  Fossel ET, McDonagh J.  Effect of field strength on the ability of water-suppressed proton NMR spectroscopy to determine malignancy: 250 MHz vs. 360 MHz.  Proceedings of the Society of Magnetic Resonance in Medicine, NY, 1987:499.

57.  Fossel ET, Dvorak HF, Carr JM, McDonagh J.  Change in aliphatic lipid proton NMR linewidths in plasma of guinea pigs injected with malignant tumor cells.  Proceedings of the Society of Magnetic Resonance in Medicine, 1987:500.

58.  Fossel ET, Eckel CG.  Proton NMR spectroscopy of normal and malignant tissue.  Proceedings of the Society of Magnetic Resonance in Medicine, 1987:973.

59.  Burstein D, Litt HI, Fossel ET.  NMR characteristics of visible intracellular  myocardial potassium.  Proceedings of the Society of Magnetic Resonance in Medicine, 1987:990.

60.  Burstein D, Fossel ET.  Effects of temperature, buffer osmolarity, and shift  reagent concentration on the intracellular sodium and potassium relaxation times.  Proceedings of the Society of Magnetic Resonance in Medicine, 1987:1045.

61.  Fossel ET.  Detection of malignancy by water-suppressed proton NMR spectroscopy of plasma.  Abstract #16.  Presented at the Fourth International ARC/NIH Symposium, Cancers in the Developed World, Bethesda, MD, 1987.

62.  Höfeler H, Scheulen ME, Schmidt CG, Fossel ET.  Water-suppressed proton nuclear magnetic resonance (NMR) spectroscopy of plasma in patients with nonseminomatous testicular cancer (NSTC).  Presented at the 17th Annual Meeting of the German Cancer Society, Frankfort, West Germany, March 1988.

63.  Fossel ET, McDonagh J.  Detection of malignancy by water-suppressed proton NMR spectroscopy of plasma.  Proceedings of the 2nd European Congress of NMR in Medicine and Biology, Berlin, West Germany, June 1988:85.

64.  Powell D, Burstein D, Fossel ET.  Studies of intracellular sodium in isolated perfused intact frog hearts:  evidence for sodium-calcium exchange.  Proceedings of the Society of Magnetic Resonance in Medicine, 1988:281.

65.  Höfeler H, Scheulen ME, Schmidt CG, Fossel ET.  Monitoring of nonseminomatous testicular cancer by water-suppressed proton nuclear magnetic resonance  spectroscopy of plasma.   Proceedings of the Society of Magnetic Resonance in Medicine, 1988:358.

66.  Fossel ET, McDonagh J, Dubinet S, Kradin R.  On the mechanism of the cancer-associated reduction of lipoprotein lipid linewidths:  tumor necrosis factor.  Proceedings of the Society of Magnetic Resonance in Medicine, 1988:364.

67.  Fossel ET.  On the biophysical behavior of lipoprotein lipids in plasma.  Proceedings of the Society of Magnetic Resonance in Medicine, 1988:365.

68.  Evans FE, Levine RA, Fossel ET.  Effect of field strength on average lipid  linewidths determined by water-suppressed proton NMR spectroscopy of plasma.  Proceedings of the Society of Magnetic Resonance in Medicine, 1988:366.

69.  Fossel ET, Carr JM, McDonagh J.  Use of water-suppressed proton NMR spectroscopy of plasma to detect breast cancer in patients with palpable and unpalpable (asymptomatic) lesions.  Proceedings of the Society of Magnetic Resonance in Medicine, 1988:367.

70.  Cheung LP, Fossel ET, Burstein D.  Sodium NMR spectroscopy of normal and  neoplastic tissues.  Proceedings of the Society of Magnetic Resonance in Medicine, 1988:451.

71.  Litt HI, Burstein D, Fossel ET.  A single and double quantum Na‑23 NMR    investigation of Na+-loaded yeast and agarose.  Proceedings of the Society of Magnetic Resonance in Medicine, 1988:452.

72.  Fossel ET.  C‑13 NMR spectra of plasma:  a potential discriminator between  hypertriglyceridemia and cancer.  Proceedings of the Society of Magnetic  Resonance in Medicine, 1988:1092.

73.  Manning WJ, Wei JY, Fossel ET, Burstein D.  Determination of left ventricular mass in the adult rat by ECG gated proton magnetic resonance imaging.  Works in Progress.  Proceedings of the Society of Magnetic Resonance in Medicine, 1988:25.

74.  Shiba E, Fossel E, Lindon J, McEver R, Salzman EW.  Glycoprotein IIb/IIIa  clustering in activated platelet, demonstrated by nuclear magnetic resonance.  Abstract #1232.  Presented at the Scientific Sessions of the American Heart Association, Washington, D.C.  Circulation 1988; 78(Suppl):II‑309.

75.  Fossel ET.  Proteins:  structure and conformation.  Abstract #2925.  Presented at the Joint ASCB/ASBMB Meeting, San Francisco, CA, 1989.

76.  Fossel ET.  Letter to the Editor.  NMR Biomed 1989; 2:87.

77.  Simon M, Fossel ET.  Potential impact of the MR spectroscopic cancer blood test on reducing the need for lung biopsy.  Abstract #1264.  Radiology 1989; 173(Suppl):401.

78.  Fossel ET, McDonagh J, Albright TE, Albright NL.  Detection of malignancy by the NMR cancer blood test in women undergoing breast biopsy.  Abstract #207.  Proceedings of the 12th Annual San Antonio Breast Cancer Symposium.  Breast Cancer Res Treat 1989; 14:184.

79.  Fossel ET, McDonagh J, Albright TE, Albright NL.  An update on the NMR cancer blood test:  water-suppressed proton NMR spectroscopy of plasma.  Proceedings of the New England Cancer Society Annual Meeting, November 1989:43-44.

80.  Fossel ET, Carr JM, Hall FM, McDonagh J.  Detection of malignancy in patients with breast lesions:  Use of H‑1 and C‑13 NMR spectroscopy of plasma.  Proceedings of the 24th National Conference on Breast Cancer (sponsored by the American College of Radiology), March 1990:6.

81.  Kritsas JJ, Fossel ET, Morgentaler A, McDonagh J, DeWolf WC.  Detection of  transitional cell carcinoma of the bladder with water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.  Abstract #330.  Presented at the American Urological Association Annual Meeting, 1990; J Urol 1990; 143(Suppl):271A.

82.  Steinberg J, Fossel ET, Morgentaler A, DeWolf WC.  Detection of testicular  cancer by water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.  Abstract #824.  Presented at the American Urological Association Annual Meeting, 1990; J Urol 1990; 143(Suppl):394A.

83.  Fossel ET, McDonagh J.  Comparison of the nuclear magnetic resonance (NMR) cancer blood test with CEA.  Abstract #495.  Proceedings of the American Society of Clinical Oncology 1990; 9:127.

84.  Fossel ET, Hui KS, McDonagh J.  Peroxidized-LDL is preferentially cytotoxic to malignant cells.  Special Conference in Cancer Research, "The Molecular Basis of Tumor Immunology" (sponsored by the American Association for Cancer Research), 1990:46.

85.  Fossel ET, McDonagh J.  Evidence for plasma lipoprotein peroxidation in 

patients with cancer.  Abstract #975.  Proceedings of the 81st Annual Meeting of the American Association for Cancer Research, May 1990; 31:164.

86.  Hui KKS, Fossel ET.  P‑31 NMR of phosphoinositide pathway stimulation.  Symposium on Molecular Mechanisms of Cellular Growth, Geisinger Foundation, Danville, PA, June 1990.

87.  Fossel ET, McDonagh J, Wilhelm OG, Bang NU.  The structure of Kringle 2 of

t-PA and its putative fibrin binding site.  Presented at the 10th International Congress on Fibrinolysis, August 1990.

88.  Fossel ET, McDonagh J.  Observation of peroxidation of LDL by C-13 NMR spectroscopy.  Works in Progress.  Proceedings of the Society of Magnetic Resonance in Medicine, 1990:1266.

89.  Smith RD, Fossel ET, Malhotra OP, Sarasua MM, Koehler KA.  Molecular dynamics calculations relevant to the functional metal ion binding behavior of the blood coagulation protein, prothrombin.  Presented at the Conference on Converging Approaches in Computational Biology, Albany, NY, September 1990.

90.  Fossel ET, McDonagh J, Albright TE, Albright HL.  Detection and monitoring of colon cancer by water-suppressed H‑1 NMR spectroscopy of plasma.  Presented at the American College of Surgeons, October 1990.

91.  Fossel ET, Albright TE, McDonagh J.  Measurement of HDL, LDL, and atherosclerotic risk index directly by curve resolution of the H-1 NMR spectrum of plasma.  Abstract #141.  Presented at the American Society of Clinical Pathologists/College of American Pathologists Fall Meeting, October 1990.

92.  Fossel ET, McDonagh J, Albright TE, Albright N.  Possible reduction in biopsy for benign breast disease:  a retrospective analysis of patients studied by the NMR cancer blood test.  Presented at the 13th Annual San Antonio Breast Cancer Symposium, November 1990.

93.  Fossel ET, Hui KKS, Fletcher JG, McDonagh J.  Presence of peroxidized LDL (pLDL) in plasma of cancer patients and its preferential cytotoxicity toward malignant cells.  Abstract #CC102.  Presented at the Keystone Symposia on Molecular & Cellular Biology January 24-February 3, 1991.  J Cell Biochem; Supplement 15C: 213.

94.  Fossel ET, Zanella CL, McDonagh J, Albright TE.  Direct measurement of LDL cholesterol by proton NMR spectroscopy of plasma.  Presented at the Cholesterol Conference of the American Heart Association (Massachusetts Affiliate), February 14, 1991.

95.  Fossel ET, McDonagh J.  Evidence for systemic lipid peroxidation in patients and animals with cancer.  Clinical Research 1991; 39:435A.

96.  Fossel ET, McDonagh J.  Alterations of plasma lipoprotein lipids in patients with cancer - evidence from C-13 nuclear magnetic resonance spectroscopy.  Abstract 83.  Proceedings of the Eighty-Second Annual Meeting of the American Association for Cancer Research, May 15-18, 1991; 32:14.

97.  Hui KKS, Konig L, Fossel ET.  Comparative studies of human malignant cells versus normal counterparts by 31P NMR spectroscopy: breast carcinoma and malignant mesothelioma.  Proceedings of the Society of Magnetic Resonance in Medicine, August 1991; 2:624.

98.  Hui KKS, Gladstone SR, Fossel ET.  31P NMR study of transmembrane signaling in Chinese hamster lung fibroblasts: role of phosphatidylethanolamine hydrolysis.  Proceedings of the Society of Magnetic Resonance in Medicine, August 1991; 2:625.

99.  Hui KKS, Konig L, Fossel ET.  31P NMR study of transmembrane signaling by vanadate stimulation in human breast carcinoma, malignant mesothelioma, and fibrosarcoma.  Proceedings of the Society of Magnetic Resonance in Medicine, August 1991; 2:626.

100. Fossel ET, McDonagh J.  Cancer-induced changes in plasma lipoproteins observed by NMR and as confirmed by gas chromatography.  Proceedings of the 102nd Meeting of the New England Cancer Society, November 1991:33.

101. Fossel ET, McDonagh J, Albright NL, Albright TE.  Detection of non-palpable breast cancer using NMR spectroscopy of plasma.  Abstract #231.  Presented at the 14th San Antonio Breast Cancer Symposium.  Br Cancer Res Treat 1991; 19:214.

102. Fossel ET, McDonagh J, Albright TE, Zanella C.  Direct measurement of LDL and HDL cholesterol simultaneously by proton NMR spectroscopy of plasma.  Abstract #110.  Proceedings of the XIV InterAmerican Congress of Cardiology, 1992:33.

103. Fossel ET.  Assessment of atherosclerotic risk based on parameters derived from the water-suppressed proton NMR spectrum of plasma.  Abstract #111.  Proceedings of the XIV InterAmerican Congress of Cardiology, 1992:33.

104. Fossel ET, Zanella CZ.  Susceptibility of plasma lipoprotein lipids to peroxidation: correlation with atherosclerotic risk.  Abstract #195.  Proceedings of the XIV InterAmerican Congress of Cardiology, 1992:57.

105. Fossel ET, Zanella C, Fletcher JG, Hui KKS.  Peroxidized-LDL cytotoxicity may be mediated by the release of lysosomal acid hydrolases.  Abstract #2531.  Proceedings of the 83rd Annual Meeting of the American Association for Cancer Research 1992; 33:424.

106. Hui KKS, Fossel ET.  Peroxidized LDL cytotoxicity is inhibited by excess LDL and enhanced by lovastatin.  Abstract #726.  Presented at the 19th International Congress of the International Academy of Pathology.  Patologķa 1992; 25:220.

107. Fossel E, Albright T, Zanella C.  Trimethylamine oxide, a component of shark blood, exhibits chemopreventitive properties.  Abstract #3281.  Proceedings of the American Association for Cancer Research 1993; 34:551.

108. Hui KKS, Jemelka I, Tan J, Mahendran N, Hilderbrand H, Sander C, Fossel ET.  Enhanced phosphatidylserine and phosphatidylethanolamine hydrolysis in CCL 39 cells stimulated with epidermal growth factor or orthovanadate.  Proceedings of the Society of Magnetic Resonance in Medicine 1993; 1:258.

109. Fossel ET, McDonagh J, Albright TE, Albright NL.  Detection of malignant disease in women undergoing breast biopsy.  H-1 and C-13 magnetic resonance spectroscopy analysis of plasma.  Proceedings of the 16th Annual San Antonio Breast Cancer Symposium, November 1993.

110. Thatte HS, Fossel ET, Shamlian PP, Jemelka I, Bridges KR.  Oxidized cholesterols in plasma of patients with sickle cell disease:  A new observation.  Abstract #1398.  Proceedings of the American Society of Hematology.  Blood 1993; 82(Suppl 1):353a.

111. Thatte HS, Jemelka I, Shamlian PP, Bridges KR, Fossel ET.  Utilization of C-13 MRS in identification of plasma lipid peroxidation differences in patients with β-thalassemia and sickle cell anemia.  Abstract #1399.  Proceedings of the American Society of Hematology.  Blood 1993; 82(Suppl 1):354a.

112. Thatte HS, Mahendran NC, Fossel ET.  Peroxidized human LDL is lethal to intraerythrocytic stages of malarial parasite in culture.  Abstract #1718.  Proceedings of the American Society of Hematology.  Blood 1993; 82(Suppl 1):433a.

113. Fossel ET, Zanella C.  Susceptibility of plasma lipoprotein lipids to peroxidation: correlation with atherosclerotic risk.  Abstract #904-60.  Proceedings of the American College of Cardiology.  JACC 1994 (Special Issue):217A.

114. Hui KKS, Fossel ET.  α-Thrombin enhanced phosphatidylserine and phosphatidylethanolamine hydrolysis in CCL 39 cells.  Abstract #480.  Proceedings of the American Association for Cancer Research 1994; 35:80.